Substituted Pyrrolidinamides III

VE6142020000004SUndetermined Publication Date: 2022-02-17GRUNENTHAL GMBH
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
VE · VE
Patent Type
Designs
Current Assignee / Owner
GRUNENTHAL GMBH
Filing Date
2020-01-10
Publication Date
2022-02-17
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art

Description

The invention relates to compounds according to the general formula (I), (I) that act as glucocorticoid receptor modulators and can be used in the treatment and / or prophylaxis of disorders that are at least partially mediated by the glucocorticoid receptor. 1. A compound according to the general formula (I), (I) where R1 represents phenyl; -C1-6-phenyl alkylene; 5- or 6-membered heteroaryl; -C1-6-alkylene (5- or 6-membered heteroaryl) or -C1-10-alkylene; R1? represents H; -C1-10-alkylene; O -CYCLOALKYLOC3-10-; R2 REPRESENTS -C(=O)-ALKYLOC1-10-; -C(=O)-CYCLOALKYLOC3-10-; -C(=O)-ALKYLENEC1-6-CYCLOALKYLOC3-10-; -C(=O)-(3-7 MEMBER HETEROCYCLOYL); -C(=O)-ALKYLENEC1-6-(3-7 MEMBER HETEROCYCLOYL); -C(=O)-PHENYL; -C(=O)-ALKYLENEC1-6-PHENYL; -C(=O)-(5- OR 6 MEMBER HETEROARYL); -C(=O)-ALKYLENEC1-6-(5- OR 6 MEMBER HETEROARYL); -S(=O)1-2-ALKYLOC1-10-; -S(=O)1-2-CYCLOALKYLOC3-10-; -S(=O)1-2-ALKYLENOC1-6-CYCLOALKYLOC3-10-;-S(=O)1-2-(3-7 MEMBERRED HETEROCYCLOYL); -S(=O)1-2-C1-6-ALKYLENE(3-7 MEMBERRED HETEROCYCLOYL); -S(=O)1-2-PHENYL; -S(=O)1-2-C1-6-ALKYLENE(PHENYL); -S(=O)1-2-(5- OR 6 MEMBERRED HETEROARYL); OR -S(=O)1-2-C1-6-ALKYLENE(5- OR 6 MEMBERRED HETEROARYL); R3 AND R3? INDEPENDENTLY OF EACH OTHER REPRESENT H; F; CL; -C1-10-ALKYL; -C3-6-CYCLOALKYL; -CH2-C3-6-CYCLOALKYL; 3- TO 7-MEMBERED HETEROCYCLOYL; -CH2-(3- TO 7-MEMBERED HETEROCYCLOYL); -CH2-PHENYL; OR -CH2-(5- OR 6-MEMBERED HETEROARYL); OR R3 AND R3? TOGETHER WITH THE CARBON ATOM TO WHICH THEY ARE ATTACHED FORM A C3-10-CYCLOYL; OR 3- TO 7-MEMBERED HETEROCYCLOYL; R4 REPRESENTS - PHENYL; -C1-6-PHENYL; 5- OR 6-MEMBERED HETEROARYL; OR -C1-6-PHENYL (5- OR 6-MEMBERED HETEROARYL); A, X, YYZ INDEPENDENTLY OF EACH OTHER REPRESENT NOT CH; WHERE AT LEAST ONE OF R1, R3 AND R3 IS NOT H;WHERE C1-10 ALKYL, AND C1-6 ALKYLENE IN EACH CASE INDEPENDENTLY OF EACH OTHER IS LINEAR OR BRANCHED, SATURATED OR UNSATURATED; WHERE C1-10 ALKYL, C1-6 ALKYLENE, C3-10 CYCLOALKYL AND 3- TO 7-MEMBERED HETEROCYCLOALKYL IN EACH CASE INDEPENDENTLY OF EACH OTHER ARE UNSUBSTITUTED OR MONO- OR POLYSUBSTITUTED WITH ONE OR MORE SUBSTITUENTS SELECTED FROM -F; -CL; -BR; -I; -CN; C1-6 ALKYL; -CF3; -CF2H; -CFH2; -CF2CL; -CFCL2; -C(=O)-C1-6 ALKYL; -C(=O)-OH; -C(=O)-OALKYLOC1-6-; -C(=O)-NH2; -C(=O)-NH(ALKYLOC1-6-); -C(=O)-N(ALKYLOC1-6-)2; -OH; =O; -OCF3; -OCF2H; -OCFH2; -OCF2CL; -OCFCL2; -O-ALKYLOC1-6-; -OC(=O)-ALKYLOC1-6-; -OC(=O)-O-ALKYLOC1-6-; -O-(CO)-NH(ALKYLOC1-6-); -OC(=O)-N(ALKYLOC1-6-)2; -OS(=O)2-NH2; -OS(=O)2-NH(ALKYLOC1-6-); -OS(=O)2-N(ALKYLOC1-6-)2; -NH2; -NH(ALKYLOC1-6-); -N(ALKYLOC1-6-)2; -NH-C(=O)-ALKYLOC1-6-; -NH-C(=O)-O-ALKYLOC1-6-; -NH-C(=O)-NH2; -NH-C(=O)-NH(ALKYLOC1-6-); -NH-C(=O)-N(ALKYLOC1-6-)2; -N(ALKYLOC1-6-)-C(=O)-ALKYLOC1-6-;-N(ALKYLOC1-6-)-C(=O)-O-ALKYLOC1-6-; -N(ALKYLOC1-6-)-C(=O)-NH2; -N(ALKYLOC1-6-)-C(=O)-NH(ALKYLOC1-6-); -N(ALKYLOC1-6-)-C(=O)-N(ALKYLOC1-6-)2; -NH-S(=O)2OH; NH-S(=O)2-ALKYLOC1-6-; -NH-S(=O)2-O-ALKYLOC1-6-; -NH-S(=O)2-NH2; -NH-S(=O)2-NH(ALKYLOC1-6-); -NH-S(=O)2N(ALKYLOC1-6-)2; -N(ALKYLOC1-6-)-S(=O)2-OH; -N(ALKYLOC1-6-)-S(=O)2-ALKYLOC1-6-; -N(ALKYLOC1-6-)-S(=O)2-O-ALKYLOC1-6-; -N(ALKYLOC1-6-)-S(=O)2-NH2; -N(ALKYLOC1-6-)-S(=O)2-NH(ALKYLOC1-6-); -N(ALKYLOC1-6-)-S(=O)2-N(ALKYLOC1-6-)2; -SCF3; -SCF2H; -SCFH2; -S-ALKYLOC1-6-; -S(=O)-ALKYLOC1-6-; -S(=O)2-ALKYLOC1-6-; -S(=O)2-OH; -S(=O)2-O-ALKYLOC1-6-; -S(=O)2-NH2; -S(=O)2-NH(C1-6-ALKYLO); -S(=O)2-N(C1-6-ALKYLO)2; C3-6-CYCLOALKYLO; 3- TO 6-MEMBERED HETEROCYCLOYL; PHENYL; 5- OR 6-MEMBERED HETEROCYCLOYL; -O-C3-6-CYCLOALKYLO; -O-(3- TO 6-MEMBERED HETEROCYCLOYL); -O-PHENYL; -O-(5- OR 6-MEMBERED HETEROCYCLOYL); -C(=O)-C3-6-CYCLOALKYLO; -C(=O)-(3- TO 6-MEMBERED HETEROCYCLOYL); -C(=O)-PHENYL;-C(=O)-(5- OR 6-MEMBERED HETEROARYL); -S(=O)2-(C3-6-CYCLOALKYLO); -S(=O)2-(3- TO 6-MEMBERED HETEROCYCLOAKYL); -S(=O)2-PHENYL OR -S(=O)2-(5- OR 6-MEMBERED HETEROARYL); WHEREIN PHENYL AND 5- OR 6-MEMBERED HETEROARYL IN EACH CASE INDEPENDENTLY OF EACH OTHER ARE UNSUBSTITUTED OR MONO- OR POLY-SUBSTITUTED WITH ONE OR MORE SUBSTITUENTS SELECTED FROM -F; -CL; -BR; -I; -CN; C1-6-ALKYL; -CF3; -CF2H; -CFH2; -CF2CL; -CFCL2; ALKYLENE-C1-4-CF3; ALKYLENE-C1-4-CF2H; ALKYLENE-C1-4-CFH2; -C(=O)-ALKYLOC1-6-; -C(=O)-OH; -C(=O)-OALKYLOC1-6-; -C(=O)-NH(OH); -C(=O)-NH2; -C(=O)-NH(ALKYLOC1-6-); -C(=O)-N(ALKYLOC1-6-)2; -OH; -OCF3; -OCF2H; -OCFH2; -OCF2CL; -OCFCL2; -O-ALKYLOC1-6-; -O-CYCLOALKYLOC3-6-; -O-(3-6 MEMBED HETEROCYCLOALKYL); -NH2; -NH(ALKYLOC1-6-); -N(ALKYLOC1-6-)2; -NH-C(=O)-ALKYLOC1-6-; -N(ALKYLOC1-6-)-C(=O)-ALKYLOC1-6-; -NH-C(=O)-NH2; -NH-C(=O)-NH(ALKYLOC1-6-); -NH-C(=O)-N(ALKYLOC1-6-)2; -N(ALKYLOC1-6-)-C(=O)-NH(ALKYLOC1-6-);-N(C1-6-ALKYLO)-C(=O)-N(C1-6-ALKYLO)2; -NH-S(=O)2-C1-6-ALKYLO; -SCF3; -S-C1-6-ALKYLO; -S(=O)-C1-6-ALKYLO; -S(=O)2-C1-6-ALKYLO; -S(=O)2-NH2; -S(=O)2-NH(C1-6-ALKYLO); -S(=O)2-N(C1-6-ALKYLO)2; C3-6-CYCLOALKYLO; C1-4-ALKYLENE-C3-6-CYCLOALKYLO; 3-6 MEMBER HETEROCYCLOYL; C1-4-ALKYLENE (3-6 MEMBER HETEROCYCLOYL); 5- OR 6-MEMBERED PHENYL OR HETEROARYL; IN THE FORM OF THE FREE COMPOUND OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF. PROVIDED THAT THE FOLLOWING COMPOUNDS ARE EXCLUDED: AMIDE OF N-[(2R,3S)-4,4-DIMETHYL-1-[1-(1-METHYL-6-OXO-1H-PYRIDIN-3-YL)-1H-INDAZOL-5-YL]-5-OXO-2-PHENYL-PYROLIDIN-3-YL]-CYCLOPROPANECARBOXYLIC ACID; N-[(2S,3R)-4,4-DIMETHYL-1-[1-(1-METHYL-6-OXO-1H-PYRIDIN-3-IL)-1H-INDAZOLE-5-IL]-5-OXO-2-PHENYL-PIR ROLIDIN-3-IL]-CYCLOPROPANECARBOXYLIC ACID AMIDE; N-[(2S,3R)-4,4-DIMETHYL-1-[1-(1-METHYL-6-OXO-1H-PYRIDIN-3-IL)-1H-INDAZOLE-5-IL]-5-OXO-2-PHENYL-PIR ROLIDIN-3-IL]-1-METHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID AMIDE;AMIDA DEL ÁCIDO N-[(2S,3R)-4,4-DIMETIL-1-[1-(1-METIL-6-OXO-1H-PIRIDIN-3-IL)-1H-INDAZOL-5-IL]-5-OXO-2-FENIL-PIR ROLIDIN-3-IL]-5-METIL-[1,2,4]OXADIAZOL-3-CARBOXÍLICO; AMIDA DEL ÁCIDO N-[(2S,3R)-4,4-DIMETIL-1-[1-(1-METIL-6-OXO-1H-PIRIDIN-3-IL)-1H-INDAZOL-5-IL]-5-OXO-2-FENIL-PIR ROLIDIN-3-IL]-4-METIL-TIAZOL-5-CARBOXÍLICO; AMIDA DEL ÁCIDO N-[(2S,3R)-4,4-DIMETIL-1-[1-(1-METIL-6-OXO-1H-PIRIDIN-3-IL)-1H-INDAZOL-5-IL]-5-OXO-2-FENIL-PIR ROLIDIN-3-IL]-TIAZOL-4-CARBOXÍLICO; Y AMIDA DEL ÁCIDO N-[(2S,3R)-4,4-DIMETIL-1-[1-(1-METIL-6-OXO-1H-PIRIDIN-3-IL)-1H-INDAZOL-5-IL]-5-OXO-2-FENIL-PIR ROLIDIN-3-IL]-5-METIL-TIAZOL-4-CARBOXÍLICO.;